James M. Anderson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
James M. Anderson has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Howard Meyerson
Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106
7 shared publicationsDavid T. Chang
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, USA
6 shared publicationsErica Colton
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio
6 shared publications- Analiz Rodriguez
Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AR
5 shared publications Takehisa Matsuda
Genome Biotechnology Laboratory, Kanazawa Institute of Technology, Ishikawa 921-8501, Japan
5 shared publicationsJacqueline A. Jones
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio 44106, USA
4 shared publications
Latest Publications
- 22 September 2026
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 114 (9) , e70154
In Vivo Assessment of a Load‐Bearing Biphasic Osteotendinous Braided Collagen Scaffold for Reconstruction of Massive Irreparable Rotator Cuff Defects
Massive, irreparable rotator cuff tears affect a significant patient population and often require invasive procedures such as allograft patch augmentation, superior capsule reconstruction, and muscle transfers due to the limited regenerative capacity and inability to reattach the rotator cuff to the humerus. Current surgical techniques primarily focus on mechanically reinforcing the tendon without promoting biological integration, leading to high re‐tear rates and functional limitations. This study aimed to evaluate OsTend, a biphasic osteotendinous scaffold designed to span the MIRC defect by bridging the muscle to the bone footprint. As such, OsTend is designed to be conducive to supporting tendon and bone regeneration while enabling muscle tissue ingrowth. OsTend consists of electrochemically aligned collagen threads braided into a three‐region scaffold: a proximal region for muscle integration, a midsection as a tendon regeneration template along with a polycaprolactone membrane as a suture rip‐stop, and a hydroxyapatite‐infused distal region to facilitate bone ingrowth. A total of 16 New Zealand White rabbits underwent unilateral infraspinatus tendon resection and repair with OsTend, followed by biomechanical testing, micro‐computed tomography, and histological analysis at 1 and 3 months postimplantation. Results demonstrated a 65% increase in ultimate tensile strength from 1 month (102.1 ± 21.5 N) to 3 months (167.9 ± 62.3 N). Tendon retraction between 1 month (7.47 ± 2.61 mm) and 3 months (6.77 ± 1.91 mm) was < 2 mm during the study period. Bone volume fraction at 1 month (24.80% ± 8.30%) and 3 months (21.52% ± 4.97%) of the footprint reached approximately 75% of the intact bone (30%). Between 1 and 3 months, the failure mode of repaired shoulders shifted from pullout at the enthesis (80% at 1 month) to rupture at the mid‐substance (100% at 3 months), indicating attainment of a functional integration between bone and scaffold over time. Histological analysis revealed collagen fiber alignment in the muscle and tendon regions and bone‐like tissue formation surrounding the hydroxyapatite‐infused region. These findings suggest that OsTend reestablishes tendon–bone attachment with structural integrity; thus, this multiphasic biotextile platform holds the potential as an off‐the‐shelf biomaterial for treating massive irreparable rotator cuff tears.
- 22 September 2026
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 114 (9) , e70154
In Vivo Assessment of a Load‐Bearing Biphasic Osteotendinous Braided Collagen Scaffold for Reconstruction of Massive Irreparable Rotator Cuff Defects
Massive, irreparable rotator cuff tears affect a significant patient population and often require invasive procedures such as allograft patch augmentation, superior capsule reconstruction, and muscle transfers due to the limited regenerative capacity and inability to reattach the rotator cuff to the humerus. Current surgical techniques primarily focus on mechanically reinforcing the tendon without promoting biological integration, leading to high re‐tear rates and functional limitations. This study aimed to evaluate OsTend, a biphasic osteotendinous scaffold designed to span the MIRC defect by bridging the muscle to the bone footprint. As such, OsTend is designed to be conducive to supporting tendon and bone regeneration while enabling muscle tissue ingrowth. OsTend consists of electrochemically aligned collagen threads braided into a three‐region scaffold: a proximal region for muscle integration, a midsection as a tendon regeneration template along with a polycaprolactone membrane as a suture rip‐stop, and a hydroxyapatite‐infused distal region to facilitate bone ingrowth. A total of 16 New Zealand White rabbits underwent unilateral infraspinatus tendon resection and repair with OsTend, followed by biomechanical testing, micro‐computed tomography, and histological analysis at 1 and 3 months postimplantation. Results demonstrated a 65% increase in ultimate tensile strength from 1 month (102.1 ± 21.5 N) to 3 months (167.9 ± 62.3 N). Tendon retraction between 1 month (7.47 ± 2.61 mm) and 3 months (6.77 ± 1.91 mm) was < 2 mm during the study period. Bone volume fraction at 1 month (24.80% ± 8.30%) and 3 months (21.52% ± 4.97%) of the footprint reached approximately 75% of the intact bone (30%). Between 1 and 3 months, the failure mode of repaired shoulders shifted from pullout at the enthesis (80% at 1 month) to rupture at the mid‐substance (100% at 3 months), indicating attainment of a functional integration between bone and scaffold over time. Histological analysis revealed collagen fiber alignment in the muscle and tendon regions and bone‐like tissue formation surrounding the hydroxyapatite‐infused region. These findings suggest that OsTend reestablishes tendon–bone attachment with structural integrity; thus, this multiphasic biotextile platform holds the potential as an off‐the‐shelf biomaterial for treating massive irreparable rotator cuff tears.
- Open Access
- 1 December 2025
- Published by Springer Nature in Regenerative Engineering and Translational Medicine
- Vol. 11 (4) , 787-788
Nicholas A. Peppas – International Ambassador for Biomaterials
- 1 December 2025
- Published by Springer Nature in Regenerative Engineering and Translational Medicine
- Vol. 11 (4) , 787-788
Open AccessNicholas A. Peppas – International Ambassador for Biomaterials
- 1 December 2024
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 37 (4) , 101597
A reflection on Arnold Caplan, the father of MSC
- 1 December 2024
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 37 (4) , 101597
A reflection on Arnold Caplan, the father of MSC
- 20 November 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 377, 236-238
Allan Hoffman – My friend
- 20 November 2024
- Published by Elsevier in Journal of Controlled Release
- Vol. 377, 236-238
Allan Hoffman – My friend
- Open Access
- 21 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (29) , eadd9871
Macrophage fusion event as one prerequisite for inorganic nanoparticle-induced antitumor response
While most nanomaterials are designed to assist tumor therapy, some inorganic nanoparticles have been reported to impede cancer development. We assume that the immune response elicited by these foreign nanoparticles might be associated with the remodeling of immune landscape in the tumor microenvironment (TME). We studied representative inorganic nanoparticles widely used in the biomedical field and first demonstrated that needle-shaped hydroxyapatite (n-nHA), granule-shaped hydroxyapatite, and silicon dioxide can effectively impair tumor progression in vivo. Substantial multinucleated giant cells (MNGCs) were formed around these antitumor nanoparticles, while the ratio of monocytes and macrophages was decreased in the TME. We found that high expression of the STXBP6 protein induced by n-nHA–treated macrophages triggers autophagy, which markedly promotes macrophage fusion into MNGCs. In this way, extensive depletion of tumor-associated macrophages in the TME was achieved, which suppressed tumor growth and metastasis. This intrinsic antitumor immunity of inorganic nanoparticles should not be neglected when designing future nanomedicines to treat cancer.
- 21 July 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (29) , eadd9871
Open AccessMacrophage fusion event as one prerequisite for inorganic nanoparticle-induced antitumor response
While most nanomaterials are designed to assist tumor therapy, some inorganic nanoparticles have been reported to impede cancer development. We assume that the immune response elicited by these foreign nanoparticles might be associated with the remodeling of immune landscape in the tumor microenvironment (TME). We studied representative inorganic nanoparticles widely used in the biomedical field and first demonstrated that needle-shaped hydroxyapatite (n-nHA), granule-shaped hydroxyapatite, and silicon dioxide can effectively impair tumor progression in vivo. Substantial multinucleated giant cells (MNGCs) were formed around these antitumor nanoparticles, while the ratio of monocytes and macrophages was decreased in the TME. We found that high expression of the STXBP6 protein induced by n-nHA–treated macrophages triggers autophagy, which markedly promotes macrophage fusion into MNGCs. In this way, extensive depletion of tumor-associated macrophages in the TME was achieved, which suppressed tumor growth and metastasis. This intrinsic antitumor immunity of inorganic nanoparticles should not be neglected when designing future nanomedicines to treat cancer.
- 1 February 2021
- Published by Elsevier in Journal of Controlled Release
- Vol. 330, 31-35
Sung Wan Kim - Early events in blood/material interactions
- 1 February 2021
- Published by Elsevier in Journal of Controlled Release
- Vol. 330, 31-35
Sung Wan Kim - Early events in blood/material interactions
- Open Access
- 10 March 2016
- Published by Oxford University Press (OUP) in Regenerative Biomaterials
- Vol. 3 (2) , 73-77
Future challenges in thein vitroandin vivoevaluation of biomaterial biocompatibility
As the science and engineering of biomaterials continues to expand with increased emphasis on the development of nanomaterials and tissue engineering scaffolds, emphasis also must be placed on appropriate and adequate approaches to the in vivo and in vitro evaluation of biomaterial biocompatibility/biological response evaluation. This article presents six topic areas that should be addressed by investigators as they move forward in the development of new systems for regenerative medicine. Most certainly, there are other areas that require attention to detail and a more complete understanding of the strengths and weaknesses of various experimental approaches to biomaterial/biological response evaluation. The small number of issues addressed in this article is only meant to bring to the attention of prospective investigators and authors, the importance of the development of adequate and appropriate evaluation techniques that address the unique features of biomaterials utilized in the development of new medical devices.
- 10 March 2016
- Published by Oxford University Press (OUP) in Regenerative Biomaterials
- Vol. 3 (2) , 73-77
Open AccessFuture challenges in thein vitroandin vivoevaluation of biomaterial biocompatibility
As the science and engineering of biomaterials continues to expand with increased emphasis on the development of nanomaterials and tissue engineering scaffolds, emphasis also must be placed on appropriate and adequate approaches to the in vivo and in vitro evaluation of biomaterial biocompatibility/biological response evaluation. This article presents six topic areas that should be addressed by investigators as they move forward in the development of new systems for regenerative medicine. Most certainly, there are other areas that require attention to detail and a more complete understanding of the strengths and weaknesses of various experimental approaches to biomaterial/biological response evaluation. The small number of issues addressed in this article is only meant to bring to the attention of prospective investigators and authors, the importance of the development of adequate and appropriate evaluation techniques that address the unique features of biomaterials utilized in the development of new medical devices.
- 18 February 2015
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 26 (3) , 1-2
Exploiting the inflammatory response on biomaterials research and development
Exploiting the inflammatory response on biomaterials research and development requires an in-depth understanding of the cellular and molecular mechanisms involved in the events comprising the tissue response continuum. Examples of how the biomaterial surface chemistry may modulate the foreign body reaction to biomaterials. The utilization of different surface chemistries on biomaterials may provide biological design criteria for the appropriate use and function of biomaterials when used in medical devices and prostheses.
- 18 February 2015
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 26 (3) , 1-2
Exploiting the inflammatory response on biomaterials research and development
Exploiting the inflammatory response on biomaterials research and development requires an in-depth understanding of the cellular and molecular mechanisms involved in the events comprising the tissue response continuum. Examples of how the biomaterial surface chemistry may modulate the foreign body reaction to biomaterials. The utilization of different surface chemistries on biomaterials may provide biological design criteria for the appropriate use and function of biomaterials when used in medical devices and prostheses.
- 17 August 2012
- Published by Springer Nature
- p. 119-149
Biomaterial-Dependent Characteristics of the Foreign Body Response and S. epidermidis Biofilm Interactions
- 17 August 2012
- Published by Springer Nature
- p. 119-149
Biomaterial-Dependent Characteristics of the Foreign Body Response and S. epidermidis Biofilm Interactions